Divestitures Greater Than $50M

July 14, 2008

Target: Maxygen Inc - Haemophilia Assets (2836)

Haemophilia asts

United States

Acquiror: Bayer Healthcare AG (2834)

Mnfr pharm prod

Germany

Deal InformationValue:

Type:

Announced:120.0

Acq. of Assets

07/02/08US - Bayer Healthcare AG, a unit of Bayer AG, agreed to acquire the Haemophilia programme assets of Maxygen Inc, a biotechnology company, for $120 mil. The consideration was to consist of $90 mil and up to $30 mil in profit-related payments.…

The full article is available to Mergers Unleashed subscribers only

Are you an existing M&A Magazine subscriber and/or ACG member?

 Yes     No

Already a print subscriber? As a print subscriber, you are entitled to online access. Please click here to activate your account.